基于粪便血红蛋白浓度和临床危险因素的结直肠癌风险分层模型的有用性
研究纳入3733例接受粪便免疫化学检测和结肠镜检查的≥50岁受试者,建立进展期结直肠肿瘤和结直肠癌的风险评分模型,分为低、中、高和极高危组;四组进展期结直肠肿瘤检出率分别为2.9%、5.3%、16.2%和35.7%,结直肠癌检出率分别为0.1%、0.5%、3.9%和11.1%。
要点
- 模型基于年龄、吸烟、糖尿病和粪便血红蛋白浓度平方根等因子进行评分。
- 风险分层可区分低、中、高和极高危组,各组进展期结直肠肿瘤和结直肠癌检出率不同。
- 作者认为该模型能有效分层风险,并为接受粪便免疫化学检测者提供准确信息。
核心结论
- 作者认为所提出的模型能有效分层进展期结直肠肿瘤和结直肠癌风险,并为接受粪便免疫化学检测的个体提供准确的风险信息。
研究设计与样本
- 回顾性分析年龄≥50岁、接受粪便免疫化学检测和结肠镜检查的受试者,使用逻辑回归分析建立进展期结直肠肿瘤和结直肠癌的风险评分模型。
主要发现
- 在3733例参与者中,367例(9.8%)患有进展期结直肠肿瘤,70例(1.9%)患有结直肠癌。
- 多变量分析显示,年龄(ß=0.043/岁)、既往吸烟(ß=0.401)、当前吸烟(ß=0.841)、糖尿病(ß=0.097)和粪便血红蛋白浓度平方根(ß=0.071)与进展期结直肠肿瘤显著相关。
- 就结直肠癌而言,年龄(ß=0.035/岁)和粪便血红蛋白浓度平方根(ß=0.004)是相关因素。
- 低、中、高和极高危组的进展期结直肠肿瘤检出率分别为2.9%、5.3%、16.2%和35.7%。
- 低、中、高和极高危组的结直肠癌检出率分别为0.1%、0.5%、3.9%和11.1%。
关键数值与推荐
- 风险分组标准:低危组风险低于粪便免疫化学检测阴性个体;中危组风险高于粪便免疫化学检测阴性但低于阳性个体;高危组风险与粪便免疫化学检测阳性个体相似;极高危组风险高于粪便免疫化学检测阳性个体。
- 进展期结直肠肿瘤多变量模型中,年龄ß=0.043/岁、既往吸烟ß=0.401、当前吸烟ß=0.841、糖尿病ß=0.097、粪便血红蛋白浓度平方根ß=0.071。
- 结直肠癌多变量模型中,年龄ß=0.035/岁、粪便血红蛋白浓度平方根ß=0.004。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We aimed to develop risk stratification models for advanced colorectal neoplasia (ACRN) and colorectal cancer (CRC) based on fecal hemoglobin (f-Hb) concentration and clinical risk factors. METHODS: We reviewed screenees aged ≥50 years who underwent fecal immunochemical test (FIT) and colonoscopy and developed risk-scoring models for ACRN and CRC using logistic regression analysis. Participants were classified into low- (risk lower than that in FIT-negative individuals), intermediate- (risk higher than that in FIT-negative but lower than that in FIT-positive individuals), high- (risk similar to that in FIT-positive individuals), and very-high- (risk higher than that in FIT-positive individuals) risk groups. RESULTS: Of 3733 participants, 367 (9.8%) and 70 (1.9%) had ACRN and CRC, respectively. On multivariable analysis, age (ß = .043/y), former smoker (ß = .401), current smoker (ß = .841), diabetes (ß = .097), and square root of f-Hb concentration (ß = .071) were significantly associated with ACRN. In terms of CRC, age (ß = .035/y) and square root of f-Hb concentration (ß = .004) were associated factors. After point assignments based on the regression coefficient, we could classify screenees as low-, intermediate-, high-, and very-high-risk groups. ACRN was identified in 2.9%, 5.3%, 16.2%, and 35.7% of screenees in the low-, intermediate-, high-, and very-high-risk groups, respectively. CRC was identified in .1%, .5%, 3.9%, and 11.1% of screenees in the low-, intermediate-, high-, and very-high-risk groups, respectively. CONCLUSIONS: The proposed models can effectively stratify the risk for ACRN and CRC and provide accurate information on this risk in individuals who undergo FIT.
引用
- Park CH, Jung YS, Kim NH, et al. Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factors. Gastrointest Endosc. 2019. PMID: 30817918. doi:10.1016/j.gie.2019.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。